GlassScriptPhysician profile
Richard Fazio
NPI 1205254638
$873.07
in general payments reported to CMS, 2019-2025
9 companies · $22.49 in 2025
The $22.49 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $625 · 2022: $129 · 2023: $59.80 · 2024: $36.52 · 2025: $22.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $365.00 | 2021-2025 | Single Use Biopsy Valve, Visiglide, Hanarostent Esophagus Tts(Ccc) |
| Conmed Corporation | $146.82 | 2021 | |
| Qol Medical, LLC | $129.37 | 2022 | |
| Abbvie INC. | $111.20 | 2021 | |
| Redhill Biopharma INC. | $39.14 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $34.02 | 2023-2024 | Lesion Hunter, Edgehog |
| Boston Scientific Corporation | $18.72 | 2023 | |
| Celgene Corporation | $14.93 | 2021 | |
| Evoke Pharma, INC. | $13.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Fazio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.